Xi'an Xintong Pharmaceutical Research Co.,ltd.

This study is testing whether a new drug called pracytarabine works better than the existing drug regorafenib for people with advanced liver cancer that has stopped responding to standard treatments. It will involve 60 adults whose cancer has continued to grow despite previous th…

This large clinical trial is testing a new medication called hepenofovir for people with chronic hepatitis B. Researchers are comparing different doses against a standard treatment to find the most effective and safest option. The goal is to better control the hepatitis B virus l…